Company intelligence / Profile preview
TikkunLev Therapeutics
Salt Lake City, Utah, United Statestikkunlev.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Demonstrated best-in-class functional recovery and survival benefits in an established large animal model of pre-existing severe non-ischemic dilated cardiomyopathy (DCM) and chronic heart failure, with long-term durability of efficacy and a highly favorable safety profile[4]
- Therapeutic areas
- Cardiovascular
- Modalities
- Gene therapyPrecision therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
University of UtahNora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI)
Beyond the preview
Go deeper on TikkunLev Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TikkunLev Therapeutics.